A review of quantitative risk-benefit methodologies for assessing drug safety and efficacy-report of the ISPOR risk-benefit management working group.

@article{Guo2010ARO,
  title={A review of quantitative risk-benefit methodologies for assessing drug safety and efficacy-report of the ISPOR risk-benefit management working group.},
  author={J. Guo and S. Pandey and J. Doyle and B. Bian and Y. Lis and D. Raisch},
  journal={Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research},
  year={2010},
  volume={13 5},
  pages={
          657-66
        }
}
  • J. Guo, S. Pandey, +3 authors D. Raisch
  • Published 2010
  • Medicine
  • Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
  • OBJECTIVE Although regulatory authorities evaluate the risks and benefits of any new drug therapy during the new drug-approval process, quantitative risk-benefit assessment (RBA) is not typically performed, nor is it presented in a consistent and integrated framework when it is used. Our purpose is to identify and describe published quantitative RBA methods for pharmaceuticals. METHODS Using MEDLINE and other Internet-based search engines, a systematic literature review was performed to… CONTINUE READING

    Paper Mentions

    ADDIS: A decision support system for evidence-based medicine
    • 132
    • PDF

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 140 REFERENCES
    When can odds ratios mislead?
    • 607